Ovid Therapeutics (OVID) Treasury Shares (2025 - 2026)

Ovid Therapeutics (OVID) posted Treasury Shares of $669545.0 for Q1 2026, up 95.8% on a QoQ basis from $341955.0 in Q3 2025.

Ovid Therapeutics (OVID) Treasury Shares (2025 - 2026) Analysis & Trends

Ovid Therapeutics' Treasury Shares history runs 2 years deep, the most recent figure standing at $669545.0 for Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Oculis Holding AG	66,621.14 Bn	66,620.85 Bn	-	-21,709.08
2	Nanobiotix	1,915.18 Bn	1,915.11 Bn	-	265,401.92
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.27 Bn	466.48 Bn	1.35 Bn	-
5	Vertex Pharmaceuticals	121.81 Bn	114.57 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	69.58 Bn	60.82 Bn	3.31 Bn	19.41 Bn
7	Belite Bio	62.72 Bn	62.72 Bn	-	-
8	Argenx Se	55.51 Bn	50.33 Bn	1.41 Bn	-
9	Revolution Medicines	37.35 Bn	37.35 Bn	-	5.14 Mn
10	Ovid Therapeutics	118.66 Mn	-36.86 Mn	-	669,545.00

Download Data